This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Mar;10(1):38-40.

doi: 10.1016/j.ebcm.2006.01.013. Epub 2006 Mar 6.

Adding tirofiban to standard pretreatment does not alter outcomes for people with non ST-elevation ACS undergoing early invasive therapy

Leonardo Bolognese¹, Debbie Singh

Affiliations

PMID: 16530677
DOI: 10.1016/j.ebcm.2006.01.013

Comment

Adding tirofiban to standard pretreatment does not alter outcomes for people with non ST-elevation ACS undergoing early invasive therapy

Leonardo Bolognese et al. Evid Based Cardiovasc Med. 2006 Mar.

. 2006 Mar;10(1):38-40.

doi: 10.1016/j.ebcm.2006.01.013. Epub 2006 Mar 6.

Authors

Leonardo Bolognese¹, Debbie Singh

Affiliation

¹ Cardiovascular Department, S. Donato Hospital, Arezzo, Italy.

PMID: 16530677
DOI: 10.1016/j.ebcm.2006.01.013

No abstract available

PubMed Disclaimer

Comment on

Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with non-ST-elevation acute coronary syndromes treated with early aggressive approach. Results of the CLOpidogrel, upstream TIrofiban, in cath Lab Downstream Abciximab (CLOTILDA) study.
Leoncini M, Toso A, Maioli M, Bellandi F, Badia T, Politi A, De Servi S, Dabizzi RP. Leoncini M, et al. Am Heart J. 2005 Sep;150(3):401. doi: 10.1016/j.ahj.2005.06.006. Am Heart J. 2005. PMID: 16169315 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science